Adam Parker

Dr. Adam S.
Parker is a Founder at Trivariate Research LP.
He also serves as a Chief Executive Officer at the firm.
Dr. Parker brings 20 years of experience in equities, including four years on the buy side and 18 years on the sell side to Trivariate Research.
Prior to Trivariate Research, Dr. Parker was the Founder & Lead Portfolio Manager of Trivariate Capital, an equity long/short hedge fund.
From 2017-2019 Adam worked as the Director of Quantitative Strategy at Eminence Capital, reporting to the CEO and Founder.
In this role, he was responsible for building a quantitative infrastructure to conduct analysis around single stock research; risk management; diagnostics of prior trades to improving sizing and timing; and macro research.
Between 2010 and early 2017, he was the Chief US Equity Strategist & Director of Global Quantitative Research at Morgan Stanley.
He was a Member of Morgan Stanley’s Global Investment Committee, a seven-person group responsible for asset allocation recommendations for the firm’s $2 trillion private wealth network.
Prolific in publishing research, he co-authored a ground-breaking paper on gender diversity as a risk factor.
He holds a Ph.D.
in Statistics from Boston University, an MS in Biostatistics from the University of North Carolina in Chapel Hill and a BS in Statistics from the University of Michigan in Ann Arbor.